Table 4 Average observation time in minutes for each stage by facility type, co-morbidity and gender
Stage | Facility type | Co-morbidity | Gender | |||||
|---|---|---|---|---|---|---|---|---|
Provincial Hospital | District Hospital | Urban Polyclinic | Tas4TB Rural | Yes | No | Female | Male | |
Registration | 1.5 (12) | 0.9 (21) | 2.1 (27) | 2.6 (7) | 3 (4) | 2.8 (12) | 1.7 (41) | 1.7 (26) |
Vital signs | 3.1 (10) | 3.3 (17) | 3.1 (27) | 3.7 (7) | 4.5 (2) | 3.5 (22) | 2.9 (34) | 3.6 (27) |
Initial Consultation | 7.1 (8) | 6.2 (17) | 7.8 (22) | 2.3 (7) | 6.1 (19) | 6.6 (32) | 6.7 (29) | 6.3 (25) |
HIV Testing Services (HTS) | 19.7 (7) | 26.6 (16) | 17 (26) | 7.1 (7) | 13.8 (5) | 20.1 (39) | 17.9 (37) | 20.7 (19) |
Diabetes Mellitus Testing Services (DM) | 11.7 (3) | 3 (3) | 7 (2) | 4.4 (7) | 6.7 (6) | 5.4 (9) | 6 (10) | 5.8 (5) |
Recording and reporting | 3.6 (5) | 5.3 (19) | 3.2 (31) | 10 (5) | 4.4 (23) | 4.7 (35) | 3.9 (31) | 5.1 (28) |
Sputum Sample Collection for TB diagnosis | 5.5 (11) | 5.9 (13) | 6 (24) | 7.9 (7) | 5.8 (25) | 6.4 (25) | 5.8 (33) | 6.6 (23) |
Sputum sample transportation | 3.2 (6) | 68.5 (13) | 54.6 (16) | 75 (7) | 51.3 (10) | 47.7 (11) | 58.4 (17) | 62.1 (21) |
Receiving and Initial registration Sputum Specimens | 2.1 (11) | 1.7 (3) | 6 (20) | 2.9 (7) | 3.4 (16) | 2.8 (14) | 3 (21) | 5.3 (19) |
Sample processing and registration of results | 88.2 (10) | 110.1 (13) | 63.5 (22) | 84.8 (8) | 42.9 (17) | 59.8 (13) | 66.7 (21) | 87.7 (29) |
Second Consultation, with sputum results | 5 (9) | 6.3 (16) | 5.9 (21) | .. | 6.1 (18) | 5.9 (24) | 5.7 (28) | 6.1 (18) |
Chest X-ray | 3.2 (6) | 3.9 (11) | 7.3 (4) | 1.7 (7) | 2.6 (8) | 3.1 (14) | 3.9 (18) | 3.3 (10) |
Consultation after Chest X-ray | .. | .. | .. | 2.3 (14) | 1.8 (6) | 2.6 (7) | 2.3 (13) | 2 (1) |
Third Consultation, for sputum negative presumptive cases | 5.3 (9) | 3.9 (11) | 11 (3) | .. | 6.6 (9) | 4.3 (13) | 5.1 (12) | 5.7 (11) |
Treatment initiation DS-TB) | 15.9 (7) | 13.4 (14) | 12.7 (6) | 11.8 (5) | 15.5 (17) | 11.4 (15) | 15.7 (12) | 12.3 (20) |
Medicines Collection (anti-TB and ancillary) | 2.5 (10) | 4.1 (19) | 5.7 (28) | 16 (3) | 6.2 (29) | 4.4 (29) | 6.4 (22) | 4.4 (38) |
Treatment follow-up | 7.4 (10) | 6.4 (14) | 6.6 (27) | .. | 6.8 (27) | 6.5 (24) | 7.2 (22) | 6.4 (27) |